![Peter Allen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Allen
Président chez BENEVOLENTAI
Fortune : 413 319 $ au 30/06/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Richard Bungay | M | 55 |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 7 ans |
Timothy Cowper | M | - |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 19 ans |
Zillah Byng-Thorne | F | 48 | 11 ans | |
Penelope Ladkin-Brand | F | 46 | 9 ans | |
Elizabeth Shanahan | F | 59 | 2 ans | |
Richard Huntingford | M | 68 | 7 ans | |
Allan Mark Watson | M | 57 |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 15 ans |
John Schoellerman | M | - | 5 ans | |
Samuel Cameron Williams | M | 55 |
Istesso Ltd.
![]() Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | 17 ans |
Tom Holgate | M | 46 | - | |
Hannah Coote | F | - | 4 ans | |
Richard Paling | M | - | 7 ans | |
Amanda Miller | F | - | 7 ans | |
Lisa Patel | M | - |
Istesso Ltd.
![]() Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
John Orloff | M | 66 | 3 ans | |
Jean Raby | M | 60 | 2 ans | |
Adrian Hennah | M | 66 | 3 ans | |
Guy Asher Harmelin | M | 45 | 4 ans | |
Douglas Le Fort | M | 58 | 3 ans | |
Ivan Griffin | M | 48 | 11 ans | |
Nigel Shadbolt | M | 68 | 4 ans | |
John Geoffery Goddard | M | 73 | 9 ans | |
William Scrimshaw | M | - | 5 ans | |
Grahame Cook | M | 66 | 3 ans | |
Anna Fullerton Batten | F | - | 2 ans | |
Fleur Wood | F | - | - | |
Sara Agee Le | M | - | 3 ans | |
Constantinos Neophytou | M | - | 4 ans | |
Catherine Tucker | F | - | 5 ans | |
Richard Compton | M | - | 8 ans | |
Sarah Lapworth | F | - | 11 ans | |
Philip Watkins | M | - | 4 ans | |
Christina Busmalis | F | - | 1 ans | |
Jessica Archer | F | - | 10 ans | |
Emma Alice Ide Stanton | F | 48 | 4 ans | |
Anne Phelan | M | 59 | 5 ans | |
Gemma Vallance | F | - |
Istesso Ltd.
![]() Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
David Keith Peters | M | - |
Istesso Ltd.
![]() Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | - |
Cathy Tomlinson | F | - | 7 ans | |
Samuel Herbert | M | 42 | 4 ans | |
Ying Li | M | - | 8 ans | |
Alan Richardson | M | 53 | 6 ans | |
Stevo Knezevic | M | - |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 14 ans |
Toshifumi Mikayama | M | 67 |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 12 ans |
Luke Edson | M | - | 6 ans | |
John O'Higgins | M | 59 | 5 ans | |
Jordan J. Herman | M | - | 3 ans | |
Andy Donnelly | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Graham David Harding | M | 58 | 2 ans | |
Richard Haley | M | - | - | |
Ian Leslie Ardill | M | 57 |
Diurnal Ltd.
![]() Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | 2 ans |
John Bowman | M | 67 | 11 ans | |
Francois Nader | M | 67 | 2 ans | |
Peter George Lutz | M | 63 | 7 ans | |
Ian James Nicholson | M | 64 |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | 14 ans |
Mark William Wood | M | 72 | 7 ans | |
Robin Andrew John Sibson | M | 65 | - | |
Mary Tavener | F | 62 | 19 ans | |
Peter Jenner | M | - |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 7 ans |
Elmar Schnee | M | 65 | 1 ans | |
John Hartup | M | 73 | 9 ans | |
Timothy Jason Sparey | M | - |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | - |
Nicholas Keher | M | 42 | 2 ans | |
Michael Venus | M | - | - | |
Sebastian Bishop | M | 48 | 7 ans | |
Madhu Davies | M | - | - | |
Peter M. Steinmann | M | 61 | 7 ans | |
Nial Ferguson | M | - | - | |
Emma Harvey | F | - | - | |
Roland Baron | M | - |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | - |
Marcello Damiani | M | 54 | 1 ans | |
Simon Estcourt | M | - | - | |
Susan Liautaud | M | - | 2 ans | |
Sharon Curran | F | 56 | 1 ans | |
Claire MacLellan | F | 46 | 6 ans | |
Wendy Becker | F | 58 | 3 ans | |
Harry Thomas Stratford | M | 54 |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 12 ans |
Penelope Freer | F | 63 | 12 ans | |
Adrian Gardner | M | 62 |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 5 ans |
Martin Abell | M | - | 4 ans | |
Ian Johnson | M | 71 | 1 ans | |
Stephen Bellamy | M | 64 | 14 ans | |
Anne Philomena Hyland | F | 64 | 4 ans | |
Manjit K. Wolstenholme | F | 59 | 6 ans | |
Auvo Antero Juhani Kaikkonen | M | 64 |
Inion Oy
![]() Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | 9 ans |
Olivier Brandicourt | M | 68 | 2 ans | |
Mark Whiteling | M | 61 | 4 ans | |
Donald W. Evans | M | 75 | 16 ans | |
Stephanie Spring | F | 66 | 5 ans | |
Hugo Drayton | M | 64 | 10 ans | |
James Hanbury | M | 60 | 2 ans | |
Paul M. Garvey | M | 71 |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | 2 ans |
Simon Poulton | M | - | - | |
Martin Brooks | M | 73 |
Abacus Group Ltd.
![]() Abacus Group Ltd. Electronics DistributorsDistribution Services Abacus Group Ltd. distributes connector, passive, electromechanical, power supply and battery products. It also provides contract manufacturing services which helps in making electronic equipment such as display peripherals. The company was founded in 1972 and is headquartered in Stevenage, the United Kingdom. | - |
Markku Silen | M | - |
Inion Oy
![]() Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | 4 ans |
Graham Grover | M | - |
Abacus Group Ltd.
![]() Abacus Group Ltd. Electronics DistributorsDistribution Services Abacus Group Ltd. distributes connector, passive, electromechanical, power supply and battery products. It also provides contract manufacturing services which helps in making electronic equipment such as display peripherals. The company was founded in 1972 and is headquartered in Stevenage, the United Kingdom. | - |
Ann Hunter | M | 68 |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 2 ans |
Michael Brennan | M | - |
Proximagen Group Plc
![]() Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Royaume-Uni | 80 | 81,63% |
Luxembourg | 16 | 16,33% |
Finlande | 2 | 2,04% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Peter Allen
- Réseau Personnel